Screener
Baxter International BAX Pharmaceuticals — Selling, general and administrative expenses
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Baxter International in its filing.
Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.
The source filing: Baxter International’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:50 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-028962
| (in millions) | Three Months Ended March 31, 2026 / Medical Products & Therapies | Three Months Ended March 31, 2026 / Healthcare Systems & Technologies | Three Months Ended March 31, 2026 / Pharmaceuticals | Three Months Ended March 31, 2025 / Medical Products & Therapies | Three Months Ended March 31, 2025 / Healthcare Systems & Technologies | Three Months Ended March 31, 2025 / Pharmaceuticals |
|---|---|---|---|---|---|---|
| Net sales | $1,285 | $705 | $621 | $1,262 | $704 | $581 |
| Cost of sales | 781 | 390 | 458 | 694 | 356 | 396 |
| Selling, general and administrative expenses | 290 | 209 | 102 | 286 | 217 | 103 |
| Research and development expenses | 54 | 49 | 22 | 59 | 45 | 26 |
| Other segment items | (26) | (9) | (7) | (21) | (7) | (7) |
| Segment operating income | $186 | $66 | $46 | $244 | $93 | $63 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Baxter International's pharmaceuticals — selling, general and administrative expenses?
- Baxter International (BAX) reported pharmaceuticals — selling, general and administrative expenses of $102M in Q1 2026.
- How has Baxter International's pharmaceuticals — selling, general and administrative expenses changed year-over-year?
- Baxter International's pharmaceuticals — selling, general and administrative expenses decreased by 1.0% year-over-year, from $103M to $102M.
- What is the long-term trend for Baxter International's pharmaceuticals — selling, general and administrative expenses?
- Over 3 years (2022 to 2025), Baxter International's pharmaceuticals — selling, general and administrative expenses has grown at a 5.9% compound annual growth rate (CAGR), from $361M to $429M.
- What does pharmaceuticals — selling, general and administrative expenses mean?
- Encompasses the operating costs required to support the Pharmaceuticals segment, including sales force compensation, marketing, legal, and administrative overhead. These expenses represent the fixed and variable costs of running the business outside of direct production.
Ask your AI about Baxter International's pharmaceuticals — selling, general and administrative expenses.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude